Novel prognostic signature unveils PSEN1 contributes to depression-induced lung adenocarcinoma progression
The molecular profile defined by the DRS can serve as an independent overall survival predictor and improve individualized treatment and clinical decision for LUAD patients. Of which, PSEN1 may contribute to depression-induced LUAD progression.
Authors
- Wenjing CHEN
- Congcong Li (ORCID: https://orcid.org/0000-0002-4459-5224)
- Qiaoqi Zheng
- Maimaititusun Yalikun (ORCID: https://orcid.org/0000-0002-6751-4431)
- Ji Zhuoga
- Jingcheng Dong
- Zaiquan Dong (ORCID: https://orcid.org/0009-0008-9668-5767)
- Peng Fu
Institutions
- Sichuan University (CN)
- Fudan University (CN)
- West China Hospital of Sichuan University (CN)
- Karamay Central Hospital (CN)
- Huashan Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-01-29
- DOI
- https://doi.org/10.3389/fimmu.2026.1681306
- Primary Topic
- Cancer, Stress, Anesthesia, and Immune Response
- Type
- article
- Field-Weighted Citation Impact
- 0.00